⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

TMO

Thermo Fisher Scientific Inc.

Healthcare · Diagnostics & Research

673.82USD

-2.7200 (-0.40%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on TMO.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$7.14▼$7.2911
Next quarter$6.05▲$5.9910
Current year$25.26▲$25.0940
Next year$27.74▲$27.4551

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-09-30$6.4$6.68+0.28 (+4.3%)
2026-06-30$5.71$6.03+0.32 (+5.5%)
2026-03-31$5.24$5.44+0.20 (+3.8%)
2025-12-31$6.45$6.57+0.12 (+1.9%)

Wall Street coverage

384 ratings from 44 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
CitigroupMaintainedBuy$685 $800Oct 23, 2026
BarclaysMaintainedOverweight$750 $775Oct 22, 2026
RBC CapitalMaintainedSector Perform$580 $730Oct 22, 2026
TD CowenMaintainedBuy$760 $810Oct 22, 2026
StifelMaintainedBuy$650 $775Oct 22, 2026
BairdMaintainedOutperform$723 $756Oct 22, 2026
Morgan StanleyMaintainedOverweight$650 $730Oct 13, 2026
TD CowenMaintainedBuy$675 $760Oct 13, 2026
BarclaysMaintainedOverweight$650 $750Oct 7, 2026
CLSAInitiatedOutperform$748Sep 3, 2026
Piper SandlerMaintainedNeutral$510 $600Jul 27, 2026
Morgan StanleyMaintainedOverweight$620 $650Jul 27, 2026
RBC CapitalMaintainedSector Perform$490 $580Jul 24, 2026
BarclaysMaintainedOverweight$625 $650Jul 24, 2026
Evercore ISI GroupMaintainedOutperform$575 $570Jul 6, 2026
Piper SandlerInitiatedNeutral$510Jun 11, 2026
HSBCDowngraded from BuyHold$670 $540Jun 3, 2026
Wells FargoMaintainedOverweight$675 $615May 8, 2026
StifelMaintainedBuy$700 $600Apr 24, 2026
BairdMaintainedOutperform$653 $639Apr 24, 2026
BarclaysMaintainedOverweight$650 $625Apr 14, 2026
Evercore ISI GroupMaintainedOutperform$650 $575Apr 6, 2026
CitigroupMaintainedBuy$660 $685Jan 30, 2026
TD CowenMaintainedBuy$696 $683Jan 30, 2026
BarclaysMaintainedOverweight$625 $650Jan 30, 2026

Insider transactions

160 filings from 29 insiders · 20 buy / 12 sell over 6m

Officers and directors of TMO, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
JOHNSON JENNIFER MDirectorGrantPhantom Stock Units46.3——Sep 26, 2026
SPERLING SCOTT MDirectorGrantPhantom Stock Units62.96——Sep 26, 2026
Lynch Karen SDirectorGrantPhantom Stock Units46.3——Sep 26, 2026
WEISLER DION JDirectorGrantPhantom Stock Units55.56——Sep 26, 2026
Keith R. AlexandraDirectorGrantPhantom Stock Units46.3——Sep 26, 2026
Pettiti GianlucaOfficer, President & COOSell400$614.38$246kAug 31, 2026
Pettiti GianlucaOfficer, President & COOExercise3.7k$309.63$1.16MAug 31, 2026
Pettiti GianlucaOfficer, President & COOSell3.7k$614.38$2.29MAug 31, 2026
Pettiti GianlucaOfficer, President & COOExerciseStock Option (Right to Buy)3.7k——Aug 31, 2026
Britt Lisa P.Officer, Sr. VP and Chief HR OfficerTax87.03$622.18$54kAug 28, 2026
Britt Lisa P.Officer, Sr. VP and Chief HR OfficerTax116.04$622.18$72kAug 28, 2026
Britt Lisa P.Officer, Sr. VP and Chief HR OfficerTax105.403$622.18$66kAug 28, 2026
Britt Lisa P.Officer, Sr. VP and Chief HR OfficerTax85.096$622.18$53kAug 28, 2026
Pettiti GianlucaOfficer, President & COOTax212.256$622.18$132kAug 28, 2026
Pettiti GianlucaOfficer, President & COOTax303.639$622.18$189kAug 28, 2026
Pettiti GianlucaOfficer, President & COOTax249.003$622.18$155kAug 28, 2026
Pettiti GianlucaOfficer, President & COOTax269.794$622.18$168kAug 28, 2026
Holmes Joseph R.Officer, VP & Chief Accounting OfficerTax10.567$622.18$7kAug 28, 2026
Holmes Joseph R.Officer, VP & Chief Accounting OfficerTax12.915$622.18$8kAug 28, 2026
Holmes Joseph R.Officer, VP & Chief Accounting OfficerTax11.447$622.18$7kAug 28, 2026

Analyst Notes

Sign in to write

No analyst notes on TMO yet.

Analyst Ratings

25 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current320301Buy2.11
1 mo ago419401Buy2.11
2 mo ago319501Buy2.18
3 mo ago319600Buy2.11
Price target$750.92$560.00 – $830.00
+11.4% to target

Top voices on TMO

Members whose judged calls on TMO have played out most reliably.

No settled calls on TMO yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice